- Aug 14, 2018
- 667
- 346
- 63
"Does Nolvadex block estrogen?" is one of the most searched questions in the nolvadex data, and the short answer — yes, but not in the way most people picture it — is worth the longer explanation. Nolvadex is the brand name for tamoxifen, and the way it interacts with estrogen is one of the most misunderstood mechanisms in the whole post cycle therapy conversation.
Tamoxifen does not lower estrogen levels in the body. It does not stop estrogen from being produced, and it does not destroy estrogen that already exists. What it does is block estrogen receptors in certain tissues — it sits in the receptor's seat so estrogen cannot. In breast tissue, that blockade is why tamoxifen is used in breast cancer treatment, and in the lifting world it is why the compound is associated with gynecomastia: by occupying the receptors in breast tissue, it prevents estrogen from acting there.
But the blockade is selective, and that selectivity is the interesting part. In some tissues tamoxifen acts as an estrogen blocker; in others it acts more like estrogen itself. In bone, for example, it has estrogen-like effects, which is part of why it does not carry the bone-density cost that a drug which simply eliminated estrogen would. This mixed behaviour is why tamoxifen belongs to a class called selective estrogen receptor modulators — SERMs — and why describing it as an "estrogen blocker" is only half true.
The distinction matters practically, too. In post cycle therapy, tamoxifen's value is not really about estrogen at all: it is about the brain. By blocking estrogen receptors in the hypothalamus and pituitary, it tricks the feedback system into thinking estrogen is low, which prompts the release of the signalling hormones that restart natural testosterone production. The estrogen-blocking effect and the recovery effect are the same mechanism wearing two different hats.
This is general information, not medical advice. Anyone weighing decisions like this should talk to a doctor first.
Did you think Nolvadex lowered estrogen itself, or did you already know it works by blocking the receptor?
Tamoxifen does not lower estrogen levels in the body. It does not stop estrogen from being produced, and it does not destroy estrogen that already exists. What it does is block estrogen receptors in certain tissues — it sits in the receptor's seat so estrogen cannot. In breast tissue, that blockade is why tamoxifen is used in breast cancer treatment, and in the lifting world it is why the compound is associated with gynecomastia: by occupying the receptors in breast tissue, it prevents estrogen from acting there.
But the blockade is selective, and that selectivity is the interesting part. In some tissues tamoxifen acts as an estrogen blocker; in others it acts more like estrogen itself. In bone, for example, it has estrogen-like effects, which is part of why it does not carry the bone-density cost that a drug which simply eliminated estrogen would. This mixed behaviour is why tamoxifen belongs to a class called selective estrogen receptor modulators — SERMs — and why describing it as an "estrogen blocker" is only half true.
The distinction matters practically, too. In post cycle therapy, tamoxifen's value is not really about estrogen at all: it is about the brain. By blocking estrogen receptors in the hypothalamus and pituitary, it tricks the feedback system into thinking estrogen is low, which prompts the release of the signalling hormones that restart natural testosterone production. The estrogen-blocking effect and the recovery effect are the same mechanism wearing two different hats.
This is general information, not medical advice. Anyone weighing decisions like this should talk to a doctor first.
Did you think Nolvadex lowered estrogen itself, or did you already know it works by blocking the receptor?